MammaPrint
MammaPrint is a prognostic and predictive diagnostic test for early stage breast cancer patients that assess the risk that a tumor will metastasize to other parts of the body.
BluePrint
a molecular subtyping test, analyzes the activity of 80 genes to enable stratification of the tumor into one of the three following
Polyerga
Spleen peptide developed in Gemarny and used more than 70 years
Ruconest Inj.
Acute seizure treatment for hereditary angioedema in adults except oropharyngeal and larynx.
ThyroSeq®
Molecular test for cytologically indeterminate thyroid nodules empowering individualized patient management.
Neoscope2020
The NeoScope Family of Rigid, Semi-Rigid and Flexible Digital Endoscopic Video system consists of a Single Use, Digital Video Endoscopes with CMOS imaging sensor and Built-in LED light source, that can be powered by commercially available Desktops, Laptops and Tablet computers.
Schebo Pancreatic Elastase1
The stool test quantifies E1 in stool, allowing the diagnosis or exclusion of pancreatic exocrine insufficiency, which can be caused by chronic pancreatitis, cystic fibrosis, pancreatic tumor, cholelithiasis or diabetes mellitus
Preparing